• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定剪接变异标志作为结肠癌的一个独立因素。

Identification of an alternative splicing signature as an independent factor in colon cancer.

机构信息

Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.

Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.

出版信息

BMC Cancer. 2020 Sep 22;20(1):904. doi: 10.1186/s12885-020-07419-7.

DOI:10.1186/s12885-020-07419-7
PMID:32962686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7510085/
Abstract

BACKGROUND

Colon cancer is a common malignant tumor with a poor prognosis. Abnormal alternative splicing (AS) events played a part in the occurrence and metastasis of the tumor. We aimed to develop a survival-associated AS signature in colon cancer.

METHODS

The Percent Spliced In values of AS events were available in The Cancer Genome Atlas (TCGA) SpliceSeq database. Univariate Cox analysis was carried out to detect the prognosis-related AS events. We created a predictive model on account of the survival-associated AS events, which was further validated with a training-testing group design. Kaplan-Meier analysis was applied to assess patient survival. The area under curve (AUC) of receiver operating characteristic (ROC) was performed to evaluate the predictive values of this model. Meanwhile, the clinical relevance of the signature and its regulatory relationship with splicing factors (SFs) were also evaluated.

RESULTS

In total, 2132 survival-related AS events were identified from colon cancer samples. We developed an eleven-AS signature, in which the 5-year AUC value was 0.911. Meanwhile, the AUC values at five years were 0.782 and 0.855 in the testing and entire cohort, respectively. Multivariate Cox regression displayed that the T category and the risk score of the signature were independent risk factors of colon cancer survival. Also, we constructed an SFs-AS network based on 11 SFs and 48 AS events.

CONCLUSIONS

We identified an eleven-AS signature of colon cancer. This signature could be treated as an independent prognostic factor.

摘要

背景

结肠癌是一种预后较差的常见恶性肿瘤。异常的选择性剪接(AS)事件在肿瘤的发生和转移中起作用。我们旨在开发一种与结肠癌生存相关的 AS 特征。

方法

TCGA SpliceSeq 数据库中提供了 AS 事件的百分比拼接值。进行单变量 Cox 分析以检测与预后相关的 AS 事件。我们基于与生存相关的 AS 事件创建了一个预测模型,并采用训练-测试组设计进行了进一步验证。Kaplan-Meier 分析用于评估患者的生存情况。接收者操作特征(ROC)曲线下面积(AUC)用于评估该模型的预测值。同时,还评估了该特征的临床相关性及其与剪接因子(SFs)的调控关系。

结果

共从结肠癌样本中鉴定出 2132 个与生存相关的 AS 事件。我们开发了一个由 11 个 AS 组成的特征,其 5 年 AUC 值为 0.911。同时,在测试集和整个队列中,该特征的 AUC 值在 5 年内分别为 0.782 和 0.855。多变量 Cox 回归显示,T 分期和特征的风险评分是结肠癌生存的独立危险因素。此外,我们还基于 11 个 SFs 和 48 个 AS 事件构建了一个 SFs-AS 网络。

结论

我们确定了结肠癌的 11 个 AS 特征。该特征可以作为独立的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/76159f17f8ff/12885_2020_7419_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/390e2fbe480d/12885_2020_7419_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/cac0721ed98d/12885_2020_7419_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/71a0153b8983/12885_2020_7419_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/3f557302f95b/12885_2020_7419_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/9a74653a02fc/12885_2020_7419_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/37bb4e21d77c/12885_2020_7419_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/f95c9de3d700/12885_2020_7419_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/e75071564fd9/12885_2020_7419_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/76159f17f8ff/12885_2020_7419_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/390e2fbe480d/12885_2020_7419_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/cac0721ed98d/12885_2020_7419_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/71a0153b8983/12885_2020_7419_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/3f557302f95b/12885_2020_7419_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/9a74653a02fc/12885_2020_7419_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/37bb4e21d77c/12885_2020_7419_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/f95c9de3d700/12885_2020_7419_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/e75071564fd9/12885_2020_7419_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/152d/7510085/76159f17f8ff/12885_2020_7419_Fig9_HTML.jpg

相似文献

1
Identification of an alternative splicing signature as an independent factor in colon cancer.鉴定剪接变异标志作为结肠癌的一个独立因素。
BMC Cancer. 2020 Sep 22;20(1):904. doi: 10.1186/s12885-020-07419-7.
2
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.基于癌症基因组图谱(TCGA)和SpliceSeq数据库的胃癌预后中可变剪接特征的综合分析
Med Sci Monit. 2020 Nov 21;26:e925772. doi: 10.12659/MSM.925772.
3
Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.口腔鳞状细胞癌中预后性可变剪接标志的鉴定。
J Cell Physiol. 2020 May;235(5):4804-4813. doi: 10.1002/jcp.29357. Epub 2019 Oct 21.
4
Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.恶性间皮瘤中与预后和免疫浸润相关的可变剪接的系统表征
BMC Cancer. 2021 Jul 22;21(1):848. doi: 10.1186/s12885-021-08548-3.
5
Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.全面分析和建立剪接事件的预测模型,揭示三阴性乳腺癌的预后预测因子和免疫微环境特征。
J Transl Med. 2020 Jul 28;18(1):286. doi: 10.1186/s12967-020-02454-1.
6
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.基于317例样本的剪接序列数据构建膀胱尿路上皮癌可变剪接事件的预后特征
Cell Physiol Biochem. 2018;48(3):1355-1368. doi: 10.1159/000492094. Epub 2018 Jul 26.
7
Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.系统分析卵巢癌预后与可变剪接的关系。
J Ovarian Res. 2021 Sep 15;14(1):120. doi: 10.1186/s13048-021-00866-1.
8
Characterization of alternative splicing events and prognostic signatures in breast cancer.乳腺癌中可变剪接事件和预后特征的分析。
BMC Cancer. 2021 May 22;21(1):587. doi: 10.1186/s12885-021-08305-6.
9
Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancer.分析复发相关的替代 mRNA 剪接,并构建预测 I-III 期结肠癌复发的预后标志物。
Genomics. 2020 Nov;112(6):4032-4040. doi: 10.1016/j.ygeno.2020.07.002. Epub 2020 Jul 6.
10
Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.基于 TCGA SpliceSeq 数据鉴定肾上腺皮质癌中与生存相关的可变剪接事件和特征。
Aging (Albany NY). 2020 Mar 26;12(6):4996-5009. doi: 10.18632/aging.102924.

引用本文的文献

1
Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease.富含人群的固有免疫变异体可能在癌症和心脏代谢疾病的交叉点确定候选基因靶点。
Front Endocrinol (Lausanne). 2024 Mar 21;14:1286979. doi: 10.3389/fendo.2023.1286979. eCollection 2023.
2
Differential Expression of Lonp1 Isoforms in Cancer Cells.Lonp1 异构体在癌细胞中的差异表达。
Cells. 2022 Dec 6;11(23):3940. doi: 10.3390/cells11233940.

本文引用的文献

1
Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancer.分析复发相关的替代 mRNA 剪接,并构建预测 I-III 期结肠癌复发的预后标志物。
Genomics. 2020 Nov;112(6):4032-4040. doi: 10.1016/j.ygeno.2020.07.002. Epub 2020 Jul 6.
2
Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.鉴定结直肠癌新型可变剪接异构体生物标志物及其与总生存期的关系。
BMC Gastroenterol. 2020 Jun 5;20(1):171. doi: 10.1186/s12876-020-01288-x.
3
Development and validation of a five-immune gene prognostic risk model in colon cancer.
开发和验证结肠癌的五个免疫基因预后风险模型。
BMC Cancer. 2020 May 6;20(1):395. doi: 10.1186/s12885-020-06799-0.
4
Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer.鉴定与结肠癌生存相关的表观遗传甲基化驱动特征和风险位点。
Ann Transl Med. 2020 Mar;8(6):324. doi: 10.21037/atm.2020.02.94.
5
Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.基于 TCGA SpliceSeq 数据鉴定肾上腺皮质癌中与生存相关的可变剪接事件和特征。
Aging (Albany NY). 2020 Mar 26;12(6):4996-5009. doi: 10.18632/aging.102924.
6
TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.TIMP1 内含子 3 保留是由 hnRNPA1 控制的结肠癌进展的标志物。
Mol Biol Rep. 2020 Apr;47(4):3031-3040. doi: 10.1007/s11033-020-05375-w. Epub 2020 Mar 21.
7
Systemic Analysis of RNA Alternative Splicing Signals Related to the Prognosis for Head and Neck Squamous Cell Carcinoma.与头颈部鳞状细胞癌预后相关的RNA可变剪接信号的系统分析
Front Oncol. 2020 Feb 7;10:87. doi: 10.3389/fonc.2020.00087. eCollection 2020.
8
Integrative analysis and validation of dysregulated long non-coding RNAs in colon cancer.结肠癌中失调长非编码 RNA 的综合分析和验证。
J Cell Mol Med. 2020 Feb;24(4):2610-2621. doi: 10.1111/jcmm.14974. Epub 2020 Jan 20.
9
Genome-wide analysis reveals the association between alternative splicing and DNA methylation across human solid tumors.全基因组分析揭示了人类实体瘤中可变剪接与DNA甲基化之间的关联。
BMC Med Genomics. 2020 Jan 6;13(1):4. doi: 10.1186/s12920-019-0654-9.
10
Development and validation of a five-lncRNA signature with prognostic value in colon cancer.具有结肠癌预后价值的五lncRNA特征的开发与验证
J Cell Biochem. 2020 Aug;121(8-9):3780-3793. doi: 10.1002/jcb.29518. Epub 2019 Nov 3.